WKHS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WKHS is not a good buy right now for an impatient investor. The broader technical trend remains bearish (SMA_200 > SMA_20 > SMA_5), near-term pattern-based stats imply higher odds of downside (next day/week/month expected -3.74%/-2.83%/-15.29%), and the latest analyst update is negative with a price target ($0.65) far below the current price (~$4.84). With no fresh positive news catalysts and ongoing weak fundamentals, the risk/reward is skewed against an immediate entry.
Trend: Bearish overall (SMA_200 > SMA_20 > SMA_5), indicating the stock is still in a longer-term downtrend. Momentum: MACD histogram +0.0831 and expanding suggests a short-term bounce attempt, but it is counter-trend versus bearish moving averages. RSI: RSI_6 at 37.13 is neutral-to-weak (not oversold), so there is no strong mean-reversion ‘forced bounce’ signal. Levels: Pivot 4.975 is overhead; price (~4.84) is below pivot, which is bearish. Support: S1 4.688 then S2 4.511. Resistance: R1 5.261 then R2 5.438. Pattern-based outlook: Similar candlestick pattern analysis shows elevated downside probability (80% chance of negative moves over 1D/1W/1M), reinforcing a poor immediate buy setup.
Intellectia Proprietary Trading Signals
Potential event-driven upside exists if the Motiv merger is successfully approved and financing is secured (the deal is the key potential catalyst mentioned by the covering analyst). Net loss improved YoY (less negative) in 2025/Q3, which is directionally supportive if the trend continues.
while keeping Neutral—signals diminished confidence and significant downside versus current price.
Latest reported quarter: 2025/Q3. Revenue: $2.38M, down 4.97% YoY (contraction). Net income: -$7.83M, improved 68.86% YoY (loss narrowing), but still deeply negative. EPS: -6.05, down 95.89% YoY (as reported in the snapshot). Gross margin: -323.17 (still negative), improved 96.25% YoY but indicates the core business is not yet operating with healthy unit economics. Overall: The quarter shows continued weak sales and ongoing losses; improvements are not yet strong enough to support an impatient buy.
Recent trend: Negative revision. On 2025-11-14, Roth Capital lowered its price target to $0.65 from $1.50 and maintained a Neutral rating, citing non-consequential Q3 results and the delayed shareholder vote for the Motiv merger; the firm would revisit after a successful merger and financing. Wall Street pros vs cons (from available data): Pros: Optionality if the Motiv merger closes and resolves strategic/financing questions. Cons: Target cut and merger-delay overhang; current price is far above the reduced target; fundamentals remain weak with shrinking revenue and ongoing losses.
